The agency first approved Soliris in 2007 to treat paroxysmal nocturnal hemoglobinuria, a rare, life-threatening blood disease. The drug may now also be used to treat adults with generalized myasthenia gravis — an autoimmune disorder that affects the body’s intramuscular system.
Soliris is the first treatment approved to treat generalized myasthenia gravis in more than 60 years.
More articles on supply chain:
Woman finds pile of ‘hundreds’ of expired medical supplies outside Dallas hospital
FDA issues warning letter to Magellan over violations related to blood-lead tests
Hospitals grapple with medical supply shortages in wake of Hurricane Maria: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
